Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 6, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

YHP2205

Test drug: YHP2205

DRUG

YHR2401

comparator: YHR2401

Trial Locations (1)

Bumin Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT06359626 - Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers | Biotech Hunter | Biotech Hunter